PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Polyphenolic extracts from pods exerted immunomodulatory, metabolic, and renoprotective effects in high-fat diet mice [PMID:37175691]
A pilot trial in 60 healthy adults evaluated the feasibility and acute postprandial glycemic response and incretin hormone modulation following a single oral dose of VF extract (1.2 mg/kg) [PMID:42005782]
Callus extract from V. farnesiana demonstrated cytotoxic activity on the HeLa cell line [PMID:39310034]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 37175691 (2023) — Vachellia farnesiana Pods or a Polyphenolic Extract Derived from Them Exert Immunomodulatory, Metabolic, Renoprotective, and Prebiotic Effects in Mice Fed a High-Fat Diet. · International journal of molecular sciences
- 2.PMID: 39310034 (2024) — Cytotoxic activity of callus extract from Vachellia farnesiana (L) Wight & Arn. · 3 Biotech
- 3.PMID: 41986833 (2026) — Short-Term Conservation and Exploitation of Sweet Acacia (Vachellia farnesiana L. Wight & Arn.) Through an Efficient Scarification-Based Germination Protocol. · Methods in molecular biology (Clifton, N.J.)
- 4.PMID: 32046254 (2020) — Characterization of Fungal Endophytes Isolated from the Metal Hyperaccumulator Plant Vachellia farnesiana Growing in Mine Tailings. · Microorganisms
- 5.PMID: 42005782